Showing 2 posts of 2 posts found.
German pharma firm Merck KGaA has agreed to hand over its CAR-T therapy business to US company Intrexon in a …
Merck Serono has announced a significant deal with Intrexon to develop and bring new cancer treatments to market. The German …
PlaqueTec coronary disease trial reaches 100 patients across eight NHS centres
PhaSER secures $2.7m Gates Foundation renewal for neglected disease drug research
Recruitment experts hired in search for new CGT Catapult chief
Envirogen secures place on NHS Scotland reverse osmosis framework
Europa Biosite enters Czech market with acquisition of diagnostics distributor